BPG is committed to discovery and dissemination of knowledge
JOURNAL HOME
Number of total visits
1931005
Number of visits today
727
Number of downloads
856669
MEMBERSHIP
BPG JOURNALS
Cited by in F6Publishing
For: Gilchrist A, Echeverria SL. Targeting Chemokine Receptor CCR1 as a Potential Therapeutic Approach for Multiple Myeloma. Front Endocrinol (Lausanne) 2022;13:846310. [PMID: 35399952 DOI: 10.3389/fendo.2022.846310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ge H, Li S, Feng J, Chu H. The Expression of Serum lncRNA MIR17HG in Patients with Multiple Myeloma and Its Clinical Significance. European Journal of Cancer Care 2023;2023:1-7. [DOI: 10.1155/2023/1728909] [Reference Citation Analysis]
2 Sang Y, Li Y, Xu L, Chen J, Li D, Du M. Dysfunction of CCR1(+) decidual macrophages is a potential risk factor in the occurrence of unexplained recurrent pregnancy loss. Front Immunol 2022;13:1045532. [PMID: 36532057 DOI: 10.3389/fimmu.2022.1045532] [Reference Citation Analysis]
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345